ZLAB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $24.33

Kapitalisasi Pasar (MRQ) $27.31B

P/E (TTM) -135.2

EPS (TTM) $-0.18

Pendapatan (TTM) $450M

ROE (TTM) -26.9%

D/E Utang/Ekuitas (MRQ) 0.4

Rentang 52M $16–$34

ZLAB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Zai Lab Limited - American Depositary Shares Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan1.784 negaraCN

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$460M

2018-12-31 → 2025-12-31

EPS$-0.16

2020-12-31 → 2025-12-31

Arus Kas Bebas$-159M

2020-12-31 → 2025-12-31

Margin bersih-41.9%

2020-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-135.2rata-rata 5T ≈-87.7	≈-87.7	·	·
P/S (TTM)	60.7rata-rata 5T ≈63.6	≈63.6	·	·
P/B (MRQ)	45.0rata-rata 5T ≈24.6	≈24.6	·	·
EV / EBITDA (TTM)	-108.5	·	·	·
Harga / FCF (TTM)	-195.7rata-rata 5T ≈-97.7	≈-97.7	·	·
Harga / Arus Kas (TTM)	-204.7rata-rata 5T ≈-101.5	≈-101.5	·	·
EV / Pendapatan (TTM)	59.9	·	·	·
EV / FCF (TTM)	-192.9	·	·	·
Harga / Nilai Buku Berwujud (MRQ)	52.4rata-rata 5T ≈26.6	≈26.6	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-58.7%rata-rata 5T ≈-185.8%	≈-185.8%	·	·
Margin EBITDA (TTM)	-55.2%rata-rata 5T ≈-182.2%	≈-182.2%	·	·
Margin Sebelum Pajak (TTM)	-42.4%rata-rata 5T ≈-179.0%	≈-179.0%	·	·
Margin Laba Bersih (TTM)	-41.9%rata-rata 5T ≈-179.1%	≈-179.1%	·	·
ROA (TTM)	-16.8%rata-rata 5T ≈-29.0%	≈-29.0%	·	·
ROE (TTM)	-26.9%rata-rata 5T ≈-36.2%	≈-36.2%	·	·
ROIC	-24.5%rata-rata 5T ≈-33.2%	≈-33.2%	·	·

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
Utang / Ekuitas (MRQ)	0.4	·	·	·
Rasio Lancar (MRQ)	2.1rata-rata 5T ≈4.6	≈4.6	·	·
Rasio Cepat (MRQ)	1.6rata-rata 5T ≈4.2	≈4.2	·	·

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	15.3%rata-rata 5T ≈66.5%	≈66.5%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	28.9%rata-rata 5T ≈48.4%	≈48.4%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	56.5%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-0.16rata-rata 5T ≈$-0.40	≈$-0.40	·	·
Revenue / Share (Pendapatan / Saham)	$0.42rata-rata 5T ≈$0.37	≈$0.37	·	·
Cash Flow / Share (Arus Kas / Saham)	$-0.14rata-rata 5T ≈$-0.19	≈$-0.19	·	·
Cash / Share (Kas / Saham)	$0.61rata-rata 5T ≈$2.98	≈$2.98	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	ZLAB	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.4rata-rata 5T ≈0.3	≈0.3	·	·
Inventory Turnover (Perputaran Persediaan)	3.3rata-rata 5T ≈3.1	≈3.1	·	·
Receivables Turnover (Perputaran Piutang)	4.8rata-rata 5T ≈5.3	≈5.3	·	·
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$257.9K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 17.0%

Periode	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	$-0.05	$-0.07	24.0%
31 Maret 2026	$-0.05	$-0.05	-4.4%
31 Des. 2025	$-0.05	$-0.07	24.0%
30 Sep. 2025	$-0.03	$-0.04	32.4%
30 Juni 2025	$-0.04	$-0.04	2.0%
31 Maret 2025	$-0.05	$-0.07	24.0%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 16

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$460M	$399M	$267M	$215M	$144M	$49M	$13M
Cost of Revenue	$191M	$147M	$96M	$74M	$52M	$17M	$4M
R&D Expense	$221M	$235M	$266M	$286M	$573M	$223M	$142M
SG&A Expense	$278M	$299M	$282M	$259M	$219M	$111M	$70M
Operating Income	$-229M	$-282M	$-367M	$-404M	$-700M	$-302M	$-203M
Interest Expense	·	$2M	$0	$0	$0	$181.0K	$293.0K
Interest Income	$33M	$37M	$40M	$15M	$2M	$5M	$8M
Other Non-op	$4M	$5M	$7M	$3M	$-10M	$7M	$938.0K
Pretax Income	$-178M	$-257M	$-335M	$-443M	$-704M	$-269M	$-194M
Income Tax	$-3M	$0	$0	$0	$0	$0	·
Net Income	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	$-195M
EPS (Basic)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
EPS (Diluted)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
Shares (Basic)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
Shares (Diluted)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
EBITDA	$-214M	$-270M	$-358M	·	$-694M	$-297M	·

Neraca 26

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$680M	$450M	$790M	$1.01B	$964M	$442M	$76M
Short-term Investments	$10M	$330M	$16M	$0	$445M	$745M	$200M
Receivables	$106M	$85M	$59M	$40M	$47M	$5M	$4M
Inventory	$75M	$40M	$45M	$32M	$19M	$13M	$6M
Prepaid Expense	$37M	$42M	$23M	$36M	$18M	$11M	$7M
Current Assets	$1.02B	$1.05B	$940M	$1.12B	$1.50B	$1.22B	$292M
PP&E (Net)	$47M	$48M	$54M	$58M	$43M	$29M	$21M
PP&E (Gross)	$90M	$85M	$84M	$80M	$60M	$39M	$27M
Accum. Depreciation	$42M	$37M	$30M	$22M	$16M	$10M	$5M
Intangibles	$76M	$56M	$13M	$2M	$2M	$2M	$1M
Other Non-current Assets	$3M	$6M	·	·	·	·	·
Total Assets	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Accounts Payable	$142M	$101M	$113M	$66M	$126M	$63M	$23M
Short-term Debt	$205M	$132M	$0	·	·	·	$6M
Current Liabilities	$416M	$299M	$203M	$140M	$193M	$98M	$47M
Capital Leases	$13M	$14M	$8M	$13M	$10M	$13M	$11M
Other Non-current Liabilities	$0	$325.0K	$325.0K	$0	·	·	·
Total Liabilities	$457M	$345M	$240M	$175M	$230M	$128M	$60M
Total Debt	$205M	$132M	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	$5.0K	$4.0K
Retained Earnings	$-2.63B	$-2.45B	$-2.20B	$-1.86B	$-1.42B	$-714M	$-445M
Treasury Stock	$29M	$21M	$21M	$12M	$4M	$0	·
AOCI	$30M	$51M	$38M	$26M	$-24M	$-15M	$5M
Stockholders' Equity	$716M	$841M	$796M	$1.05B	$1.38B	$1.17B	$295M
Liabilities + Equity	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Shares Outstanding	1,106,389,340	1,082,614,740	977,151,270	962,455,850	955,363,980	878,110,260	682,372,470

Arus Kas 13

Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$15M	$12M	$9M	$8M	$6M	$5M	$4M
Stock-based Comp	$66M	$71M	$80M	$61M	$41M	$25M	$20M
Amort. of Intangibles	$6M	$3M	$700.0K	$500.0K	$500.0K	$300.0K	$305.0K
Other Non-cash	$-56M	$-40M	$48M	·	$108M	$23M	·
Operating Cash Flow	$-151M	$-215M	$-198M	$-368M	$-549M	$-216M	$-191M
CapEx	$8M	$6M	$7M	$25M	$18M	$10M	$6M
Investing Cash Flow	$308M	$-375M	$-11M	$420M	$250M	$-555M	$-15M
Stock Issued	$0	$217M	$0	$0	·	·	·
Net Stock Activity	$0	$217M	·	·	·	·	·
Financing Cash Flow	$72M	$350M	$-6M	$-2M	$820M	$1.13B	$219M
Net Change in Cash	$230M	$-240M	$-218M	$44M	$522M	$366M	$13M
Free Cash Flow	$-159M	$-221M	$-205M	·	$-568M	$-226M	·
Levered FCF	·	$-223M	·	·	·	·	·

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-49.9%	-70.7%	-137.4%	·	-485.1%	-616.5%	·
Net Margin	-38.1%	-64.4%	-125.5%	·	-488.2%	-549.3%	·
Pretax Margin	-38.8%	-64.4%	-125.5%	·	-487.4%	-549.3%	·
EBITDA Margin	-46.6%	-67.7%	-134.1%	·	-480.6%	-607.0%	·
ROA	-14.9%	-23.1%	-29.7%	·	-48.5%	-32.5%	·
ROE	-23.3%	-34.1%	-39.9%	·	-47.5%	-23.3%	·
ROIC	-24.5%	-29.0%	-46.1%	·	·	·	·

Likuiditas & Solvabilitas 4

Metrik	2025	2024	2023	2022	2021	2020	2019
Current Ratio	2.4	3.5	4.6	·	7.8	12.4	·
Quick Ratio	1.9	2.9	4.3	·	7.6	12.2	·
Debt / Equity	0.3	0.2	·	·	·	·	·
Interest Coverage	·	-125.2	·	·	·	-1667.4	·

Efisiensi 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.4	0.4	0.2	·	0.1	0.1	·
Inventory Turnover	3.3	3.5	2.5	·	3.3	1.7	·
Receivables Turnover	4.8	5.5	5.4	·	5.5	10.9	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$0.65	$0.78	$0.82	·	$14.44	$13.32	·
Revenue / Share	$0.42	$0.40	$0.28	·	·	·	·
Cash Flow / Share	$-0.14	$-0.22	$-0.21	·	·	·	·
Cash / Share	$0.61	$0.42	$0.81	·	$10.09	$5.03	·
EPS (TTM)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·

Tingkat Pertumbuhan 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	15.3%	49.6%	24.0%	49.0%	194.8%	·	·
Revenue CAGR 3Y	28.9%	40.4%	76.0%	·	·	·	·
Revenue CAGR 5Y	56.5%	·	·	·	·	·	·

Valuasi (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$460M	$399M	$267M	$215M	$144M	$49M	·
Net Income TTM	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	·
Market Cap	$19.52B	$28.23B	$26.57B	·	$6.00B	$11.88B	·
Enterprise Value	$19.03B	$27.58B	·	·	·	·	·
P/E	-110.2	-100.7	-78.1	-66.7	-82.7	-386.7	·
P/S	42.4	70.7	99.6	·	41.6	242.7	·
P/B	27.3	33.6	33.4	·	4.4	10.2	·
P / Tangible Book	30.5	36.0	33.9	28.2	4.4	10.2	·
P / Cash Flow	-129.4	-131.4	-134.1	·	-10.9	-55.0	·
P / FCF	-122.8	-128.0	-129.4	·	-10.6	-52.5	·
EV / EBITDA	-88.8	-102.0	·	·	·	·	·
EV / FCF	-119.8	-125.1	·	·	·	·	·
EV / Revenue	41.4	69.1	·	·	·	·	·
Earnings Yield	-0.91%	-0.99%	-1.3%	-1.5%	-1.2%	-0.26%	·

Laporan Laba Rugi 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$106M	$100M	$128M	$116M	$110M	$106M	$109M	$102M	$101M	$87M	$66M	$69M	$69M	$63M	$63M	$58M
Cost of Revenue	$48M	$38M	$62M	$47M	$43M	$38M	$42M	$37M	$35M	$34M	$25M	$25M	$24M	$21M	$21M	$20M
R&D Expense	$62M	$66M	$62M	$48M	$51M	$61M	$52M	$66M	$62M	$55M	$82M	$59M	$77M	$48M	$67M	$100M
SG&A Expense	$73M	$65M	$73M	$70M	$71M	$63M	$83M	$67M	$80M	$69M	$83M	$69M	$68M	$63M	$72M	$67M
Operating Income	$-76M	$-69M	$-69M	$-49M	$-55M	$-56M	$-68M	$-68M	$-76M	$-70M	$-124M	$-84M	$-90M	$-70M	$-97M	$-129M
Interest Expense	·	·	·	·	·	·	·	·	·	$113.0K	·	·	·	$0	·	·
Interest Income	$6M	$6M	$7M	$8M	$9M	$9M	$9M	$9M	$9M	$10M	$10M	$9M	$10M	$10M	$9M	$4M
Other Non-op	$5M	$162.0K	$495.0K	$-508.0K	$4M	$-197.0K	$1M	$3M	$-9M	$9M	$7M	$394.0K	$-1M	$1M	$10M	$4M
Pretax Income	$-52M	$-50M	$-53M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
Income Tax	$-1M	$1M	$-3M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$-51M	$-51M	$-50M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
EPS (Basic)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
EPS (Diluted)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
Shares (Basic)	1,116,973,380	1,107,390,590	·	1,102,072,680	1,091,933,150	1,080,825,300	·	981,687,390	975,937,790	973,145,760	·	968,767,730	964,817,310	961,444,780	·	959,085,960
Shares (Diluted)	1,116,973,380	1,107,390,590	·	1,102,072,680	1,091,933,150	1,080,825,300	·	981,687,390	975,937,790	973,145,760	·	968,767,730	964,817,310	961,444,780	·	959,085,960
EBITDA	$-76M	$-65M	·	$-49M	$-55M	$-53M	·	$-68M	$-76M	$-67M	·	$-84M	$-90M	$-67M	·	$-129M

Neraca 26

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$608M	$651M	$680M	$717M	$732M	$757M	$450M	$616M	$630M	$651M	·	$789M	$859M	$880M	·	$1.12B
Short-term Investments	$10M	$10M	$10M	$0	$0	$0	$330M	$0	$0	$0	·	$32M	$16M	$51M	·	$0
Receivables	$70M	$54M	$106M	$85M	$88M	$77M	$85M	$50M	$70M	$60M	·	$42M	$47M	$43M	·	$28M
Inventory	$91M	$86M	$75M	$67M	$62M	$53M	$40M	$40M	$42M	$38M	·	$44M	$36M	$38M	·	$29M
Prepaid Expense	$33M	$35M	$37M	$44M	$41M	$44M	$42M	$36M	$20M	$24M	·	$30M	$38M	$43M	·	$22M
Current Assets	$914M	$945M	$1.02B	$1.03B	$1.03B	$1.04B	$1.05B	$861M	$870M	$889M	·	$960M	$1.02B	$1.07B	·	$1.21B
PP&E (Net)	$46M	$47M	$47M	$49M	$50M	$50M	$48M	$51M	$51M	$52M	·	$55M	$56M	$58M	·	$51M
PP&E (Gross)	$94M	$92M	$90M	$89M	$89M	$89M	$85M	$87M	$85M	$85M	·	$83M	$82M	$83M	·	$71M
Accum. Depreciation	$47M	$45M	$42M	$41M	$39M	$39M	$37M	$36M	$34M	$32M	·	$28M	$26M	$24M	·	$20M
Intangibles	$86M	$76M	$76M	$55M	$57M	$56M	$56M	$52M	$44M	$12M	·	$2M	$2M	$1M	·	$2M
Other Non-current Assets	$4M	$3M	$3M	$2M	$3M	$3M	$6M	·	·	·	·	·	·	·	·	·
Total Assets	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Accounts Payable	$137M	$126M	$142M	$100M	$107M	$103M	$101M	$121M	$127M	$88M	·	$55M	$67M	$66M	·	$90M
Short-term Debt	$238M	$214M	$205M	$203M	$175M	$173M	$132M	$113M	$70M	$48M	·	·	·	·	·	·
Current Liabilities	$429M	$393M	$416M	$360M	$332M	$320M	$299M	$286M	$252M	$192M	·	$125M	$133M	$125M	·	$156M
Capital Leases	$11M	$12M	$13M	$11M	$11M	$12M	$14M	$6M	$6M	$8M	·	$10M	$12M	$13M	·	$14M
Other Non-current Liabilities	$225.0K	$40.0K	$0	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	·	$325.0K	$325.0K	$325.0K	·	·
Total Liabilities	$468M	$434M	$457M	$399M	$372M	$363M	$345M	$318M	$283M	$226M	·	$163M	$174M	$169M	·	$193M
Total Debt	$238M	$214M	·	$203M	$175M	$173M	·	$113M	$70M	$48M	·	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Retained Earnings	$-2.73B	$-2.68B	$-2.63B	$-2.58B	$-2.54B	$-2.50B	$-2.45B	$-2.37B	$-2.33B	$-2.25B	·	$-2.10B	$-2.03B	$-1.91B	·	$-1.80B
Treasury Stock	$34M	$31M	$29M	$29M	$21M	$21M	$21M	$21M	$21M	$21M	·	$21M	$21M	$17M	·	$11M
AOCI	$214.0K	$15M	$30M	$40M	$46M	$49M	$51M	$28M	$43M	$39M	·	$48M	$52M	$17M	·	$40M
Stockholders' Equity	$607M	$662M	$716M	$760M	$792M	$811M	$841M	$668M	$704M	$762M	$796M	$881M	$932M	$1.00B	$1.05B	$1.11B
Liabilities + Equity	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Shares Outstanding	1,122,445,390	1,110,232,620	1,106,389,340	1,105,865,950	1,099,112,890	1,084,164,200	1,077,702,540	984,356,170	981,398,140	973,285,510	977,151,270	969,037,150	968,566,280	963,688,740	962,455,850	959,724,940

Arus Kas 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$2M	$2M
Stock-based Comp	$12M	$14M	$16M	$17M	$17M	$16M	$17M	$17M	$19M	$18M	$20M	$22M	$21M	$17M	$16M	$19M
Amort. of Intangibles	$2M	$2M	$1M	$2M	$2M	$2M	$1M	$700.0K	$800.0K	$700.0K	$200.0K	$200.0K	·	·	·	·
Other Non-cash	·	$22M	·	·	·	$-33M	·	·	·	$-58M	·	·	·	$-39M	·	·
Operating Cash Flow	$-63M	$-12M	$-26M	$-32M	$-31M	$-62M	$-56M	$-27M	$-42M	$-90M	$-15M	$-55M	$-59M	$-69M	$-109M	$-126M
CapEx	$1M	$1M	$677.0K	$3M	$3M	$2M	$3M	$1M	$741.0K	$974.0K	$222.0K	$2M	$2M	$4M	$4M	$7M
Investing Cash Flow	$-1M	$-22M	$-11M	$-4M	$-3M	$326M	$-348M	$-30M	$-846.0K	$3M	$14M	$-14M	$43M	$-54M	$-4M	$568M
Financing Cash Flow	$19M	$6M	$-430.0K	$21M	$9M	$43M	$238M	$42M	$22M	$48M	$393.0K	$-1M	$-1M	$-4M	$-199.0K	$709.0K
Net Change in Cash	$-44M	$-28M	$-38M	$-15M	$-25M	$308M	$-166M	$-14M	$-21M	$-39M	$666.0K	$-70M	$-20M	$-128M	$-111M	$439M
Free Cash Flow	·	$-13M	·	·	·	$-63M	·	·	·	$-91M	·	·	·	$-73M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-91M	·	·	·	·	·	·

Profitabilitas 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-72.0%	-69.7%	·	-42.0%	-49.9%	-52.9%	·	-66.3%	-75.7%	-80.7%	·	-120.7%	-130.0%	-110.7%	·	-223.5%
Net Margin	-47.8%	-51.2%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
Pretax Margin	-48.8%	-49.8%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
EBITDA Margin	-72.0%	-65.7%	·	-42.0%	-49.9%	-49.6%	·	-66.3%	-75.7%	-77.2%	·	-120.7%	-130.0%	-106.5%	·	-223.5%
ROA	-4.5%	-4.5%	·	-3.4%	-3.8%	-4.5%	·	-4.1%	-7.7%	-5.0%	·	-5.9%	-9.6%	-3.7%	·	-10.7%
ROE	-7.3%	-6.9%	·	-5.0%	-5.5%	-6.2%	·	-5.4%	-9.8%	-6.1%	·	-7.0%	-11.3%	-4.3%	·	-12.0%
ROIC	-8.9%	-8.2%	·	-5.1%	-5.7%	-5.7%	·	-8.7%	-9.8%	-8.7%	·	-9.5%	-9.6%	-6.9%	·	-11.6%

Likuiditas & Solvabilitas 4

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	2.1	2.4	·	2.9	3.1	3.3	·	3.0	3.5	4.6	·	7.7	7.6	8.6	·	7.8
Quick Ratio	1.6	1.8	·	2.2	2.5	2.6	·	2.3	2.8	3.7	·	6.9	6.9	7.8	·	7.4
Debt / Equity	0.4	0.3	·	0.3	0.2	0.2	·	0.2	0.1	0.1	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-622.2	·	·	·	·	·	·

Efisiensi 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.0	·	0.0
Inventory Turnover	0.6	0.6	·	0.9	0.8	0.8	·	0.9	0.9	0.9	·	0.7	0.8	0.7	·	1.0
Receivables Turnover	1.3	1.5	·	1.7	1.4	1.6	·	2.2	1.7	1.7	·	2.0	1.9	1.6	·	2.4

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.54	$0.60	·	$0.69	$0.72	$0.75	·	$0.68	$0.72	$0.78	·	$0.91	$0.96	$1.04	·	$1.15
Revenue / Share	$0.10	$0.09	·	$0.11	$0.10	$0.10	·	$0.10	$0.10	$0.09	·	$0.07	$0.07	$0.07	·	$0.06
Cash Flow / Share	·	$-0.01	·	·	·	$-0.06	·	·	·	$-0.09	·	·	·	$-0.07	·	·
Cash / Share	$0.54	$0.59	·	$0.65	$0.67	$0.70	·	$0.63	$0.64	$0.67	·	$0.81	$0.89	$0.91	·	$1.17
EPS (TTM)	$-0.18	$-0.17	·	$-0.20	$-0.21	$-0.25	·	$-0.27	$-0.30	$-0.35	·	$-0.31	$-0.41	$-0.42	·	$-0.63

Valuasi (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$450M	$453M	·	$442M	$428M	$418M	·	$356M	$323M	$291M	·	$263M	$252M	$231M	·	$197M
Net Income TTM	$-188M	$-178M	·	$-207M	$-213M	$-252M	·	$-271M	$-298M	$-339M	·	$-301M	$-393M	$-410M	·	$-593M
Market Cap	$21.33B	$20.88B	·	$37.48B	$38.44B	$39.18B	·	$23.76B	$17.01B	$15.59B	·	$23.56B	$26.86B	$32.05B	·	$32.82B
Enterprise Value	$20.95B	$20.44B	·	$36.96B	$37.88B	$38.60B	·	$23.26B	$16.45B	$14.99B	·	·	·	·	·	·
P/E	-105.6	-110.6	·	-169.4	-166.5	-144.6	·	-89.4	-57.8	-45.8	·	-78.4	-67.6	-79.2	·	-54.3
P/S	47.4	46.1	·	84.9	89.8	93.7	·	66.8	52.7	53.6	·	89.4	106.7	138.7	·	166.9
P/B	35.1	31.5	·	49.3	48.5	48.3	·	35.6	24.2	20.5	·	26.7	28.8	32.0	·	29.7
P / Tangible Book	40.9	35.6	·	53.2	52.3	51.9	·	38.6	25.8	20.8	·	26.8	28.9	32.1	·	29.7
P / Cash Flow	·	-1753.1	·	·	·	-635.0	·	·	·	-173.0	·	·	·	-462.6	·	·
EV / Revenue	46.6	45.1	·	83.7	88.5	92.3	·	65.4	51.0	51.5	·	·	·	·	·	·
Earnings Yield	-0.95%	-0.90%	·	-0.59%	-0.60%	-0.69%	·	-1.1%	-1.7%	-2.2%	·	-1.3%	-1.5%	-1.3%	·	-1.8%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$460M	$399M	$267M	$215M	$144M
Margin Operasi %	-49.9%	-70.7%	-137.4%	·	-485.1%
Laba Bersih	$-176M	$-257M	$-335M	$-443M	$-704M
EPS Dilusian	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utang / Ekuitas	0.3	0.2	·	·	·
Rasio Lancar	2.4	3.5	4.6	·	7.8
Rasio Cepat	1.9	2.9	4.3	·	7.6

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-159M	$-221M	$-205M	·	$-568M

Pemilik institusional (13F) 97 pengaju · $813.8M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 97

Nilai yang dipegang $813.8M

Posisi baru 16

Posisi yang keluar 21

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
16 (-4 vs Kuartal sebelumnya)	21 (-20 vs Kuartal sebelumnya)	29 (+5 vs Kuartal sebelumnya)	26 (-17 vs Kuartal sebelumnya)	+15.2M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
RTW INVESTMENTS, LP	$124.906.608	6.574.032	15,35%	Saham
TCG Crossover Management, LLC	$116.614.913	6.137.627	14,33%	Saham
RA CAPITAL MANAGEMENT, L.P.	$109.127.127	5.743.533	13,41%	Saham
ADAR1 Capital Management, LLC	$64.011.646	3.369.034	7,87%	Saham
FMR LLC	$53.489.066	2.815.214	6,57%	Saham
GOLDMAN SACHS GROUP INC	$43.994.120	2.315.480	5,41%	Saham
Woodline Partners LP	$41.938.567	2.207.293	5,15%	Saham
Frazier Life Sciences Management, L.P.	$36.144.080	1.902.320	4,44%	Saham
BAMCO INC /NY/	$30.850.186	1.623.694	3,79%	Saham
TWO SIGMA INVESTMENTS, LP	$24.688.486	1.299.394	3,03%	Saham
CITADEL ADVISORS LLC	$24.409.414	1.284.706	3,00%	Saham
Rock Springs Capital Management LP	$15.479.433	814.707	1,90%	Saham
BlackRock, Inc.	$12.624.778	664.462	1,55%	Saham
JANE STREET GROUP, LLC	$9.054.279	476.541	1,11%	Saham
B Group, Inc.	$8.562.274	450.646	1,05%	Saham
SCHRODER INVESTMENT MANAGEMENT GROUP	$7.238.204	393.167	0,89%	Saham
NAN FUNG TRINITY (HK) LTD	$6.582.854	346.466	0,81%	Saham
Aberdeen Group plc	$5.914.586	311.294	0,73%	Saham
CITIGROUP INC	$5.714.725	300.775	0,70%	Saham
Spruce Street Capital LP	$5.303.090	279.110	0,65%	Saham
AMERIPRISE FINANCIAL INC	$4.810.249	253.171	0,59%	Saham
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$4.692.658	246.982	0,58%	Saham
Hudson Bay Capital Management LP	$4.085.000	215.000	0,50%	Saham
JANE STREET GROUP, LLC	$3.864.600	203.400	0,47%	Opsi jual
Nantahala Capital Management, LLC	$3.800.000	200.000	0,47%	Saham
NEXTBio Capital Management LP	$3.483.878	183.362	0,43%	Saham
SUPERSTRING CAPITAL MANAGEMENT LP	$2.960.447	155.813	0,36%	Saham
Seven Fleet Capital Management LP	$2.924.756	136.016	0,36%	Saham
MARSHALL WACE, LLP	$2.797.123	147.217	0,34%	Saham
D. E. Shaw & Co., Inc.	$2.682.002	141.158	0,33%	Saham
Privium Fund Management B.V.	$2.321.591	122.189	0,29%	Saham
STATE STREET CORP	$2.296.074	120.846	0,28%	Saham
AXA Investment Managers S.A.	$2.230.436	65.814	0,27%	Saham
ALPS ADVISORS INC	$2.098.189	110.431	0,26%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.086.200	109.800	0,26%	Opsi jual
DIMENSIONAL FUND ADVISORS LP	$1.934.621	101.997	0,24%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.454.735	76.565	0,18%	Saham
Legal & General Group Plc	$1.358.116	71.461	0,17%	Saham
UBS Group AG	$1.319.626	69.454	0,16%	Saham
Orion Portfolio Solutions, LLC	$1.310.400	36.259	0,16%	Saham
Virtus Investment Advisers, LLC	$1.294.356	68.124	0,16%	Saham
Headlands Technologies LLC	$1.292.190	68.010	0,16%	Saham
MORGAN STANLEY	$1.242.619	65.401	0,15%	Saham
DCF Advisers, LLC	$1.206.500	63.500	0,15%	Saham
CITADEL ADVISORS LLC	$953.800	50.200	0,12%	Opsi jual
Quadrature Capital Ltd	$741.532	39.028	0,09%	Saham
WOLVERINE TRADING, LLC	$714.581	21.700	0,09%	Opsi jual
WealthPlan Investment Management, LLC	$698.459	36.761	0,09%	Saham
NORTHERN TRUST CORP	$455.601	23.979	0,06%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$453.701	23.879	0,06%	Saham

Tampilkan semua 97 pemilik institusional →

Orang dalam perusahaan 20 orang dalam · 11 pejabat · 10 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Beli 12m	Jual 12m	Bersih 12m
Ying Du	Chairperson & CEO	2 Juli 2026 A	1.221.401	0	15	$-8.578.643
Yajing Chen	Chief Financial Officer	19 Agu 2026 S	35.635	0	7	$-223.642
William Ki Chul Cho	Chief Financial Officer	3 April 2023 M	53.747	0	0	$0
Joshua L Smiley	President and Chief Operating Officer	6 April 2026 S	117.602	0	3	$-294.354
Rafael Amado	President, Head of Global Oncology Research and Development	6 April 2026 S	57.022	0	5	$-674.984
Harald Reinhart	President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases	25 Juni 2024 M	62.619	0	0	$0
Yi Liang	CCO & President, Greater China	25 Juni 2022 A	104.847	0	0	$0
Tao Fu	President & COO	28 Okt. 2021 S	77.500	0	0	$0
Frazor Titus Edmondson III	Chief Legal Officer	25 Juni 2026 M	30.346	0	8	$-1.005.489
Yizhe Wang	Operating Partner	11 Mei 2026 A	·	0	0	$0
Alan B. Sandler	Head of Global Dev., Oncology	25 Juni 2022 A	28.985	0	0	$0
Richard Gaynor	Direktur	1 Juli 2026 P	80.737	2	0	$65.804
Nisa Leung	Direktur	17 Juni 2026 A	96.297	0	0	$0
Michel Vounatsos	Direktur	17 Juni 2026 A	72.787	0	0	$0
Scott W Morrison	Direktur	17 Juni 2026 A	56.904	0	0	$0
John D. Diekman	Direktur	17 Juni 2026 A	122.140	0	0	$0
MOULDER LEON O JR	Direktur	17 Juni 2026 A	94.973	0	0	$0
WIRTH PETER	Direktur	17 Juni 2026 A	416.121	0	0	$0
Kai-Xian Chen	Direktur	31 Des. 2024 D	39.525	0	0	$0
William Lis	·	12 Agu 2026 S	41.931	0	2	$-340.004

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 8 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
BBP · ETFis Series Trust I	1,47%	79.505 NS	31 Juli 2026	N-PORT
PGJ · Invesco Exchange-Traded Fund Trust	0,86%	28.106 SH	2 Okt. 2026	Harian
IBB · iShares Trust	0,16%	684.677 SH	11 Sep. 2026	Harian
IBBQ · Invesco Exchange-Traded Fund Trust …	0,08%	3.144 SH	2 Okt. 2026	Harian
DFEM · Dimensional ETF Trust	0,01%	26.020 NS	31 Juli 2026	N-PORT
DFSE · Dimensional ETF Trust	0,01%	1.660 NS	31 Juli 2026	N-PORT
DFAE · Dimensional ETF Trust	0,00%	10.010 NS	31 Juli 2026	N-PORT
DFAX · Dimensional ETF Trust	0,00%	2.911 NS	31 Juli 2026	N-PORT

ZLAB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 15 analis BELI

Target median $31.84 +30,9%

2 13,3% Beli Kuat

10 66,7% Beli

3 20,0% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

12 analis · 2026-09-29

Target rata-rata $33.14 +36,2%

Sekarang Harga saat ini $24.33

Rendah$24.25 Rata-rata$33.14 Tinggi$50.00

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Zai Lab (ZLAB), Amgen (AMGN) Bermitra untuk Mengevaluasi Terapi Kombinasi Kanker Paru Yahoo Finance · 5 bulan, 2 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

ZLAB Zai Lab Limited - American Depositary Shares

ZLAB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

ZLAB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Tentang Zai Lab Limited - American Depositary Shares Tinjauan perusahaan dari Wikipedia

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Pemilik institusional (13F) 97 pengaju · $813.8M total · Per tanggal 30 Juni 2026

Orang dalam perusahaan 20 orang dalam · 11 pejabat · 10 direktur

Kepemilikan ETF Dimiliki oleh 8 ETF

ZLAB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap